NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE
Post# of 341
Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, will be participating in two upcoming investor conferences. The company announced that CEO Doug Drysdale will be presenting virtually in a fireside chat during the Cantor Virtual Global Healthcare Conference and, during the Benzinga Healthcare Small Cap Conference, Drysdale will be presenting and participating in a panel discussion. The Benzinga conference is scheduled for Thursday, Sept. 30, 2021, and Drysdale’s presentation is scheduled for 12:15 p.m. ET. According to the announcement, Drysdale will also be involved in a panel discussion titled “Addressing Mental Health through Emerging Therapies” immediately following his presentation. On the same day, Drysdale will be presenting during the Benzinga conference; his presentation is slated to begin at 2 p.m. ET, with a replay of the presentation available for 90 days following the live webcast.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer